Researchers at the National University of Singapore (NUS) have developed a novel catalytic process that converts epoxides into fluorinated oxetanes—highly sought-after drug molecules previously ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its ...